Please login to view this media
- Talk
- 23/06/2023
- CANADA
Multicenter Clinical Trial of a Continuous Compartmental Pressure Device in Patients with Long Bone Fractures
Description
In this presentation, Dr. Ross Leighton discusses a study focused on the safety and functionality of a new device, MY01, designed for continuous pressure monitoring to aid in the early detection of acute compartment syndrome (ACS). He begins by thanking the contributors to the study and acknowledges the various hospitals involved in the multicenter, prospective non-randomized control trial. Dr. Leighton emphasizes the challenge in diagnosing ACS due to the subjective nature of pain and the limitations of current examination methods.
The device aims to address concerns about potentially missing cases of compartment syndrome or performing unnecessary fasciotomies, ultimately reducing risk for patients. He details the ease of use of the device, which connects to a smartphone for real-time pressure monitoring, and discusses the demographics of the patient population studied, primarily male patients with injuries to long bones, particularly the tibia.
Dr. Leighton shares key findings from the study, including that 100 patients were evaluated, with some experiencing actual compartment syndrome which validated the device's effectiveness. He highlights the overall positive feedback regarding the device, with a notable 94% ease of usage reported. Clinical examples illustrate its practical application, showing how the pressure readings helped guide surgical decisions in patient cases. He notes the importance of monitoring trends in pressure readings in conjunction with clinical symptoms to assess the risk of ACS accurately.
Conclusions drawn by Dr. Leighton suggest a shift in how pressure monitoring should be approached, advocating for a comprehensive view that includes monitoring trends alongside numerical values and patient symptoms. He envisions that continued use of such devices could improve outcomes in surgeries, particularly in patients at risk for ACS, ultimately providing a reliable method for early detection of this serious condition.